255 related articles for article (PubMed ID: 15466114)
1. Severe infantile hypercalcemia associated with Williams syndrome successfully treated with intravenously administered pamidronate.
Cagle AP; Waguespack SG; Buckingham BA; Shankar RR; Dimeglio LA
Pediatrics; 2004 Oct; 114(4):1091-5. PubMed ID: 15466114
[TBL] [Abstract][Full Text] [Related]
2. Severe hypercalcemia associated with Williams syndrome successfully treated with pamidronate infusion therapy.
Sangun O; Dundar BN; Erdogan E
J Pediatr Endocrinol Metab; 2011; 24(1-2):69-70. PubMed ID: 21528818
[TBL] [Abstract][Full Text] [Related]
3. Long-term control of hypercalcaemia in an infant with williams-Beuren syndrome after a single infusion of biphosphonate (Pamidronate).
Oliveri B; Mastaglia SR; Mautalen C; Gravano JC; Pardo Argerich L
Acta Paediatr; 2004 Jul; 93(7):1002-3. PubMed ID: 15303821
[TBL] [Abstract][Full Text] [Related]
4. Acute renal failure due to severe hypercalcemia and nephrocalcinosis treated with two doses of pamidronate in an infant with Williams-Beuren syndrome.
Baştuğ F; Nalçacıoğlu H; Baş VN; Tekatlı-Çelik B; Çetinkaya H; Yel S
Turk J Pediatr; 2018; 60(2):210-215. PubMed ID: 30325132
[TBL] [Abstract][Full Text] [Related]
5. Use of disodium pamidronate in children with hypercalcemia awaiting liver transplantation.
Attard TM; Dhawan A; Kaufman SS; Collier DS; Langnas AN
Pediatr Transplant; 1998 May; 2(2):157-9. PubMed ID: 10082449
[TBL] [Abstract][Full Text] [Related]
6. Severe immobilization-induced hypercalcemia in a child after liver transplantation successfully treated with pamidronate.
Profumo RJ; Reese JC; Foy TM; Garibaldi LR; Kane RE
Transplantation; 1994 Jan; 57(2):301-3. PubMed ID: 8310527
[No Abstract] [Full Text] [Related]
7. Safety of pamidronate in patients with renal failure and hypercalcemia.
Machado CE; Flombaum CD
Clin Nephrol; 1996 Mar; 45(3):175-9. PubMed ID: 8706358
[TBL] [Abstract][Full Text] [Related]
8. Use of bisphosphonates for resistant hypercalcemia in children with acute lymphoblastic leukemia: report of two cases and review of the literature.
Andiran N; Alikaşifoğlu A; Küpeli S; Yetgin S
Turk J Pediatr; 2006; 48(3):248-52. PubMed ID: 17172070
[TBL] [Abstract][Full Text] [Related]
9. Pamidronate for long-term control of hypercalcemia associated with Williams syndrome.
Ismail J
Indian Pediatr; 2015 Feb; 52(2):163-4. PubMed ID: 25691196
[No Abstract] [Full Text] [Related]
10. Combination of calcitonin and pamidronate for emergency treatment of malignant hypercalcemia.
Sekine M; Takami H
Oncol Rep; 1998; 5(1):197-9. PubMed ID: 9458321
[TBL] [Abstract][Full Text] [Related]
11. Malignant hypercalcemia in pregnancy: effect of pamidronate on uterine contractions.
Culbert EC; Schfirin BS
Obstet Gynecol; 2006 Sep; 108(3 Pt 2):789-91. PubMed ID: 17018504
[TBL] [Abstract][Full Text] [Related]
12. Pamidronate: Treatment for severe hypercalcemia in neonatal subcutaneous fat necrosis.
Alos N; Eugène D; Fillion M; Powell J; Kokta V; Chabot G
Horm Res; 2006; 65(6):289-94. PubMed ID: 16612105
[TBL] [Abstract][Full Text] [Related]
13. Importance of dietary calcium and vitamin D in the treatment of hypercalcaemia in Williams-Beuren syndrome.
Lameris AL; Geesing CL; Hoenderop JG; Schreuder MF
J Pediatr Endocrinol Metab; 2014 Jul; 27(7-8):757-61. PubMed ID: 24572979
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D intoxication and hypercalcaemia in an infant treated with pamidronate infusions.
Ezgu FS; Buyan N; Gündüz M; Tümer L; Okur I; Hasanoglu A
Eur J Pediatr; 2004 Mar; 163(3):163-5. PubMed ID: 14714183
[TBL] [Abstract][Full Text] [Related]
15. A case of resistant hypercalcemia of malignancy with a proposed treatment algorithm.
McMahan J; Linneman T
Ann Pharmacother; 2009 Sep; 43(9):1532-8. PubMed ID: 19622757
[TBL] [Abstract][Full Text] [Related]
16. Severe hypercalcemia without hypercalciuria in a previously healthy infant.
Clark BC; Fleming R; Spaeder MC; Tuchman S
J Pediatr Endocrinol Metab; 2012; 25(1-2):187-90. PubMed ID: 22570974
[TBL] [Abstract][Full Text] [Related]
17. Intravenous pamidronate in the treatment of severe idiopathic infantile hypercalcemia.
Skalova S; Cerna L; Bayer M; Kutilek S; Konrad M; Schlingmann KP
Iran J Kidney Dis; 2013 Mar; 7(2):160-4. PubMed ID: 23485543
[TBL] [Abstract][Full Text] [Related]
18. Pamidronate treatment for hypercalcemia in an infant receiving parenteral nutrition.
Bryowsky JJ; Bugnitz MC; Hak EB
Pharmacotherapy; 2004 Jul; 24(7):939-44. PubMed ID: 15303458
[TBL] [Abstract][Full Text] [Related]
19. [Acute lymphoblastic leukemia accompanied by severe hypercalcemia; successful treatment with bisphosphonate].
Ogihara T; Kikuchi Y; Imai Y; Ohsaka A; Isaka M; Oka Y
Rinsho Ketsueki; 1995 Jan; 36(1):29-34. PubMed ID: 7715075
[TBL] [Abstract][Full Text] [Related]
20. The use of pamidronate for hypercalcemia secondary to acute vitamin D intoxication.
Lee DC; Lee GY
J Toxicol Clin Toxicol; 1998; 36(7):719-21. PubMed ID: 9865241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]